Aclacinomycin A is an anthracycline drug. It sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. It is used in the treatment of cancer.
CAS Number:
[66676-88-8]
Target:
Siwenmycin , Aclacinomycins
* VAT and and shipping costs not included. Errors and price changes excepted